POTTER & MOORE PLC

Financial Health Assessment: POTTER & MOORE PLC

1. Financial Health Score: B- (Incomplete Examination)

Explanation: Based on the available qualitative and structural data, the patient exhibits a strong pulse—evidenced by long-term survival, strict regulatory compliance, and a robust governance structure. However, a definitive A-F grade regarding financial wellness cannot be confirmed without viewing the quantitative "blood work" (the filed annual accounts and profit & loss figures). The recent name change suggests the business is undergoing some form of corporate evolution or restructuring, making the missing financial data highly significant.

2. Key Vital Signs

• Corporate Longevity (Genetics): Excellent. Incorporated in 1975, this business has survived multiple economic cycles. Surviving nearly 50 years in the competitive consumer goods sector indicates a resilient underlying business model.
• Regulatory Compliance (Pulse & Heartbeat): Strong. The company's accounts and confirmation statements are up to date, with no overdue filings. This indicates a healthy, regular corporate heartbeat and a lack of administrative distress.
• Corporate Structure (Skeletal System): Robust but Heavy. As a Public Limited Company (PLC) operating as a Group, the business has a large board of 9 directors and a corporate secretary (ONE ADVISORY LIMITED). This provides strong governance oversight (a sturdy skeleton), but such a large board can also lead to increased administrative overhead.
• Ownership & Control (Blood Type): Concentrated. Mr. William Oliver Mcilroy holds between 25% and 50% of the shares. While this provides strong, stable leadership, it also means minority shareholders have limited voting power against the PSC.
• Financial Metrics (Blood Pressure & Cholesterol): Unknown. The critical quantitative vital signs—turnover, fixed/current assets, current liabilities, net current assets, and P&L reserves—are notably absent from the patient's chart. Without these, we cannot measure profitability, liquidity, or leverage.

3. Diagnosis

Based on the observable symptoms, Potter & Moore PLC (formerly Creightons PLC) presents as a compliant, long-standing corporate entity that is currently undergoing a notable identity shift.

The most prominent symptom is the recent name change from Creightons PLC to Potter & Moore PLC in April 2026. In corporate health, a name change of this magnitude for a nearly 50-year-old institution is rarely cosmetic. It typically points to one of the following underlying conditions: 1. Strategic Rebranding: A pivot in market positioning, perhaps moving away from the "Creightons" heritage to embrace the "Potter & Moore" brand identity, which may resonate better with their target market for skincare, haircare, and wellbeing products. 2. M&A Activity: A merger, acquisition, or spin-off that necessitated a change in the corporate moniker to reflect new ownership structures while retaining the PLC shell.

The lack of filed financial numbers makes it impossible to diagnose if the company is suffering from poor cash flow, high debt, or margin compression. However, the fact that the company is actively filing its compliance documents on time and maintaining a full board suggests it is not currently in a state of administrative or financial collapse.

4. Recommendations

To ensure continued financial wellness and achieve a clean bill of health, the following actions are recommended:

1. Complete the Blood Work: Urgently review the latest filed annual accounts at Companies House once they become available. You must assess the Net Current Assets (working capital) to ensure the company can meet its short-term debts, and the P&L Reserve to verify long-term retained profits.
2. Monitor the "Rebrand" Symptoms: Investigate the business rationale behind the shift from Creightons to Potter & Moore. Stakeholders should ensure that the costs of this rebranding (packaging, marketing, web updates) do not cause a temporary cash flow hemorrhage.
3. Governance Checkup: With 9 directors on the board, evaluate whether the board size is efficient for the company's current revenue scale. An oversized board can sometimes lead to slow decision-making and inflated administrative expenses.
4. Review PSC Strategy: Ensure that the strategic direction driven by the 25-50% shareholder aligns with the broader corporate vision, particularly following the recent name change, to prevent governance friction.